scholarly journals Undersized angioplasty and stenting of symptomatic intracranial tight stenosis with Enterprise: Evaluation of clinical and vascular outcome

2015 ◽  
Vol 22 (2) ◽  
pp. 187-195 ◽  
Author(s):  
Kun-Yu Lee ◽  
David Yen-Ting Chen ◽  
Hui-Ling Hsu ◽  
Chi-Jen Chen ◽  
Ying-Chi Tseng
Keyword(s):  
Medical Therapy ◽  
Arterial Stenosis ◽  
Modified Rankin Scale ◽  
Intracranial Arterial Stenosis ◽  
Stent Deployment ◽  
Technical Success Rate ◽  
Stent Restenosis ◽  
Intracranial Atherosclerotic Disease ◽  
Stenotic Lesions

Background Severe intracranial arterial stenosis results in more than 10% incidence of stroke and transient ischemic attack. Using undersized angioplasty with off-label closed-cell Enterprise stent may be a feasible alternative option for treating patients with intracranial atherosclerotic disease who fail dual-antiplatelet medical therapy. The results of the authors’ study are presented in this paper. Materials and methods Between January 2013 and July 2014, 24 symptomatic patients with a total of 30 intracranial arterial stenotic lesions refractory to medical therapy, who underwent undersized angioplasty and Enterprise stenting, were retrospectively reviewed in the authors’ institution. The results evaluated include technical success rate, clinical outcome measured as modified Rankin Scale at presentation and follow-up, peri-procedural morbidity within 30 days and 1 year, and follow-up vessel patency. Results Stent deployment was successfully achieved in all stenotic lesions (30/30). Mean pre-stent and post-stent diameter residual stenosis was 81% and 18%, respectively. The peri-procedural complication rate during 30 days after stenting was 10% per lesion (3/30), including intracranial hemorrhage, in-stent thrombosis and ischemic stroke. No further thromboembolic event or complication occurred in any patient more than 30 days after stenting. Modified Rankin scale ≤ 2 was observed in 64% and 83% of patients at initial presentation and follow-up (mean 15.8 months), respectively. Imaging follow-up was available in 17 of 24 patients (70.8%) and 20 of 30 treated lesions (66.6%) with a mean follow-up period of 15.4 months. Only one asymptomatic in-stent restenosis occurred in 20 available lesions (5.0%). Conclusion This preliminary study suggests that using undersized angioplasty and Enterprise stenting may effectively treat high-degree symptomatic intracranial arterial stenosis with favorable clinical and angiographic outcome.

scholarly journals Role of Stenting for Intracranial Atherosclerosis in the Post-SAMMPRIS Era

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Dale Ding ◽  
Robert M. Starke ◽  
R. Webster Crowley ◽  
Kenneth C. Liu
Keyword(s):  
Inclusion Criteria ◽  
Technical Success ◽  
Endovascular Stenting ◽  
Technical Success Rate ◽  
Stent Restenosis ◽  
Intracranial Atherosclerotic Disease ◽  
Number Of Patients ◽  
Ischemic Events

Introduction. The initial promise of endovascular stenting for the treatment of intracranial atherosclerotic disease (ICAD) has been tempered by the results of the SAMMPRIS trial which demonstrated better outcomes with medical management compared to stenting for symptomatic ICAD. We review post-SAMMPRIS ICAD stenting outcomes.Methods. A comprehensive literature search was performed using PubMed to identify all ICAD stenting series published after the SAMMPRIS in September 2011. The type and design of the stent, number of patients and lesions, inclusion criteria, and clinical and angiographic outcomes were noted.Results. From October 2011 to August 2013, 19 ICAD stenting series were identified describing the interventional outcomes for 2,196 patients with 2,314 lesions. Of the 38 different stents used, 87% were balloon-expandable stents (BESs) and 13% were self-expanding stents. The median minimum stenosis was 50%. The median rates of technical success rate, postprocedural ischemic events, and symptomatic in-stent restenosis (ISR) were 98% (range 87–100%), 9.4% (range 0–25%), and 2.7% (range 0–11.1%), respectively. The median follow-up durations were one to 67 months.Conclusions. The management of severe ICAD remains controversial. Future trials are needed to define the optimal patient, lesion, and stent characteristics which will portend the best outcomes with intervention.

Use of Heparin-coated Stents in Neurovascular Interventional Procedures: Preliminary Experience with 10 Patients

Neurosurgery ◽  
2006 ◽  
Vol 59 (4) ◽  
pp. 812-821 ◽  
Author(s):  
Richard J. Parkinson ◽  
Christopher P. Demers ◽  
Joseph G. Adel ◽  
Elad I. Levy ◽  
Eric Sauvageau ◽  
...  
Keyword(s):  
Clinical Symptoms ◽  
Cerebrovascular Circulation ◽  
Clinical History ◽  
Published Data ◽  
Anterior Circulation ◽  
Stent Deployment ◽  
Stent Restenosis ◽  
Intracranial Atherosclerotic Disease ◽  
Small Series

Abstract OBJECTIVE: Currently, there is minimal published data on the use of heparin-coated stents in the neurovasculature; however, these stents have a proven clinical record in the treatment of coronary disease. This article details our experience with the safety and technical aspects of stent deployment in the first 10 patients who had heparin-coated stents placed in the intracranial and cervical vasculature and the preliminary follow-up in most cases. METHODS: We retrospectively reviewed the clinical history, intra- and periprocedural data, and imaging for the patients who received heparin-coated stents in the cervical and intracranial vasculature for cerebrovascular disease between October 2002 and October 2003. RESULTS: Thirteen heparin-coated stents were placed in 10 patients. Seven out of the 10 patients had heparin-coated stents placed in the posterior circulation; the remaining three patients had stents placed in the anterior circulation. Four patients had stents placed intracranially. There was no acute or subacute in-stent thrombosis and no procedure-related complications. Follow-up was performed on most patients, with no clinical symptoms attributable to restenosis in any patient. CONCLUSION: This small series suggests that heparin-coated stents are safe for use in the treatment of cervical and intracranial atherosclerotic disease. Longer-term follow-up is needed to study the heparin coating effect on in-stent restenosis rates and to assess the long-term durability and clinical efficacy of this stent. The use of drug-coated stents in the cerebrovascular circulation is an area that warrants further investigation.

Republished: Endovascular recanalisation with drug coated balloon for chronic symptomatic middle cerebral artery total occlusion

2018 ◽  
Vol 10 (9) ◽  
pp. e24-e24 ◽  
Author(s):  
Jun Zhang ◽  
Xiao Zhang ◽  
Jin-Ping Zhang ◽  
Ju Han
Keyword(s):  
Middle Cerebral Artery ◽  
Medical Therapy ◽  
Cerebral Artery ◽  
De Novo ◽  
Total Occlusion ◽  
Good Outcome ◽  
Stent Restenosis ◽  
Drug Coated Balloon ◽  
In Stent Restenosis

The optimal treatment for patients with chronic symptomatic middle cerebral artery (MCA) total occlusion is not well established. In addition to medical therapy, vessel recanalisation with stenting has shown much promise, especially for patients with recurrent ischemic symptoms. Nevertheless, the incidence of symptomatic in-stent restenosis (ISR) is high, and is associated with an unfavorable prognosis. Drug coated balloons (DCBs) have been proven to be effective in treating and preventing ISR. However, the feasibility of DCBs for de novo intracranial atherothrombotic stenosis has not been previously described, especially for total occlusion lesions. Here we reported a patient with chronic left MCA total occlusion successfully treated with DCBs, with a good outcome at the 1 year follow-up. More studies are warranted to further compare the efficacy of DCBs and stentings for intracranial revascularisation.

scholarly journals Instantaneous Wave-Free Ratio Measurement During Intracranial Submaximal Angioplasty: Case Series and 2-Dimensional Operative Video

2020 ◽  
Vol 19 (4) ◽  
pp. 422-428
Author(s):  
Kunal Vakharia ◽  
Muhammad Waqas ◽  
Najya Fayyaz ◽  
Amanda Young ◽  
Elad I Levy ◽  
...  
Keyword(s):  
Case Series ◽  
Length Of Hospital Stay ◽  
Interventional Cardiology ◽  
Arterial Stenosis ◽  
Intracranial Arterial Stenosis ◽  
Ratio Measurement ◽  
Pressure Wire ◽  
Before And After ◽  
Stenosis Severity

Abstract BACKGROUND Instantaneous wave-free ratios (iFRs) are functional measures of arterial stenosis that have become essential to interventional cardiology procedures. Their use for intracranial submaximal angioplasty (angioplasty with an undersized balloon) has not been studied extensively. OBJECTIVE To describe the feasibility and technique of iFR measurement for stenosis assessment during intracranial angioplasty. METHODS We present a series of consecutive patients treated between January 1, 2017 and June 30, 2018 with submaximal intracranial angioplasty in whom pre- and postprocedure iFR measurements were obtained with a Verrata-Volcano pressure wire (Philips, Amsterdam, The Netherlands). We collected patient data on age, sex, comorbid conditions, presenting complaints, modified Rankin scale (mRS) score at admission, neurological findings, procedure duration, fluoroscopy time, intraprocedural complications, length of hospital stay, and mRS score at last clinical follow-up (favorable outcome, 0-2). Angiographic stenosis severity and iFR values were recorded before and after angioplasty. RESULTS A total of 12 patients underwent iFR-guided angioplasty during the study period. The median patient age was 69.5 yr (range 48-81 yr). All patients had symptomatic intracranial arterial stenosis (3-basilar, 2-vertebral, 6-middle cerebral, 1-internal carotid). Preangioplasty stenosis ranged from 55% to 90%. The median postangioplasty reduction in stenosis was 17% (range 9%-30%). Preangioplasty values ranged from 0.30 to 0.40 (n = 4). Postangioplasty values ranged from 0.6 to 0.9 (n = 5). iFR values improved considerably in all patients. No procedure-related complications occurred. The median follow-up was 8.9 mo (range 3-25 mo). Follow-up outcomes were favorable in 10 patients. CONCLUSION iFR measurement before and after intracranial angioplasty is feasible. It may be used to assess the adequacy of intracranial angioplasty.

The Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis Trial: Reanalysis Using the FDA “On Label” Criteria

2020 ◽  
Vol 30 (6) ◽  
pp. 857-861
Author(s):  
Adnan I. Qureshi ◽  
Muhammad F. Ishfaq ◽  
Vamshi K. S. Balasetti ◽  
Iryna Lobanova ◽  
Guven Uzun ◽  
...  
Keyword(s):  
Medical Therapy ◽  
Arterial Stenosis ◽  
Intracranial Arterial Stenosis

Changes in intracranial stenotic lesions after extracranial-intracranial bypass surgery

1984 ◽  
Vol 60 (4) ◽  
pp. 771-776 ◽  
Author(s):  
Issam Awad ◽  
Anthony J. Furlan ◽  
John R. Little
Keyword(s):  
Bypass Surgery ◽  
Internal Carotid Artery Stenosis ◽  
Artery Stenosis ◽  
Arterial Stenosis ◽  
Intracranial Arterial Stenosis ◽  
Content Type ◽  
Stenotic Lesion ◽  
Bypass Patency ◽  
History Of ◽  
Stenotic Lesions

✓ The natural history of intracranial arterial stenosis is not well understood. The lesions are pathologically quite diverse, and are subject to resolution, progression, or occlusion. The authors undertook an investigation to examine what effects, if any, extracranial-intracranial (EC-IC) bypass surgery had on the evolution of intracranial arterial stenosis in 18 patients undergoing EC-IC bypass procedures for ipsilateral hemispheric ischemia. There was inaccessible internal carotid artery stenosis in 14 patients, and middle cerebral artery stenosis in four patients. Early (within 2 weeks) and late (at 6 months) postoperative angiography was performed in all patients. During the period of the study, there was a significant change in the arterial stenosis in 50% of the patients (nine of 18). The stenotic artery became occluded in four patients while the grafts were widely patent. The occlusion occurred within a few days after the operation in three of the four cases, and was accompanied by an ischemic stroke in these patients. There was improvement or resolution of the stenotic lesion in five patients; the graft became occluded in two of these cases and was patent but showed poor cortical artery filling in the other three. All these patients remained asymptomatic and the change was detected on routine late postoperative angiograms. It is concluded that arterial stenoses should not be viewed as static or inflexible lesions, and that EC-IC bypass procedures can modify the hemodynamic parameters across stenotic lesions, predisposing them to improvement or worsening. This, in turn, may affect bypass patency. Such hemodynamic interactions are accompanied by ischemic symptoms in some patients, and contribute to the relatively higher morbidity associated with EC-IC bypass surgery in the setting of arterial stenosis.

Bypass surgery in patients with intracranial stenotic lesions

1985 ◽  
Vol 62 (4) ◽  
pp. 532-538 ◽  
Author(s):  
Collice Massimo ◽  
Arena Orazio ◽  
Filizzolo Felice
Keyword(s):  
Cerebral Artery ◽  
Postoperative Morbidity ◽  
Neurological Complications ◽  
High Rate ◽  
Arterial Stenosis ◽  
Content Type ◽  
Stenotic Arteries ◽  
Stenotic Lesions ◽  
Very High

✓ Postoperative morbidity in patients with intracranial stenotic lesions following extracranial-intracranial arterial (EC-IC) bypass is not well defined. A high rate of neurological complications associated with occlusion of the stenotic arteries after surgery has recently been reported. In the period June, 1976, to March, 1984, the authors performed EC-IC bypass procedures in 19 patients with intracranial stenotic arteries. Most of the patients were initially treated pharmacologically (usually by anticoagulant therapy). Surgery was performed if the symptoms recurred while the patients were under pharmacological treatment and if angiography confirmed arterial stenosis. Antiplatelet therapy was given until the day of surgery and during the entire follow-up period. No permanent postoperative morbidity was observed in the series. One patient, with stenosis of the left siphon, the A1 segment of the anterior cerebral artery, and the M1 segment of the middle cerebral artery, had a transient dysphasia and right hemiparesis (lasting 3 days) in the presence of an unchanged arterial stenosis. In five patients early postoperative angiography (at 5 to 21 days) revealed occlusion of previously stenotic arteries. In one patient the occlusion was disclosed only on a later angiographic study, 2 months after surgery. Although EC-IC bypass is generally not a very high-risk operation in patients with intracranial arterial stenosis, there is a high percentage of immediate postoperative occlusion, and the authors suggest caution in determining indication for surgical treatment.

scholarly journals Familial Presentation of Intracranial Occlusive Arteriopathy and Ischemic Stroke in Patients with Graves’ Hyperthyroidism

2015 ◽  
Vol 11 (02) ◽  
pp. 89
Author(s):  
Priyank Khandelwal ◽  
Nirav Shah ◽  
Tannvi Prakash ◽  
Gustavo Ortiz ◽  
◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Arterial Stenosis ◽  
Graves Disease ◽  
Intracranial Arterial Stenosis ◽  
Ischemic Event ◽  
First Report ◽  
Mother And Daughter ◽  
Occlusive Arteriopathy

Background:The comorbidity of intracranial occlusive arteriopathy and Graves’ disease (GD) is increasingly being reported.Methods:We describe two patients (mother and daughter) with GD, intracranial occlusive arteriopathy, and ischemic strokes.Results:Both patients were thyrotoxic at the time of the ischemic event, and the intracranial arterial stenosis was progressive while in thyrotoxic state. In one of the cases, there was no further progression of the disease after 1 year of follow up, once hyperthyroidism was well controlled.Conclusion:To the best of our knowledge, this is the first report of familial presentation of moyamoya-like vasculopathy in patients with GD in Latin population.

Sign in / Sign up

Export Citation Format

Share Document